Cargando…
Management of the Rheumatoid Arthritis Patient with Interstitial Lung Disease
The treatment of rheumatoid arthritis (RA) has undergone considerable changes over the last 15–20 years. With an expansion in the armamentarium of therapies available for RA comes a wider choice in selecting the best treatment in terms of comparative safety in the presence of comorbidities. Clinicia...
Autores principales: | Jani, Meghna, Dixon, William G., Matteson, Eric L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120764/ http://dx.doi.org/10.1007/978-3-319-68888-6_9 |
Ejemplares similares
-
The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease
por: Liang, Minrui, et al.
Publicado: (2022) -
Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review
por: Matteson, Eric L., et al.
Publicado: (2023) -
Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis
por: Bluett, James, et al.
Publicado: (2017) -
Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis
por: Wilton, Katelynn M., et al.
Publicado: (2017) -
Rheumatoid arthritis-associated interstitial lung disease
por: Solomon, Joshua J, et al.
Publicado: (2012)